# Allemagne – Produits pharmaceutiques – Open House Originale Rabattverträge 2025-05 - Emtricitabin/Tenofovirdisoproxil/Rilpivirin (Wirkstoffkombination)

Acheteur : Techniker Krankenkasse.  Pays : Allemagne.  CPV : 33600000.

Source: QUOTA CÔTE — https://quotacote.com/opportunites/allemagne-produits-pharmaceutiques-open-house-originale-rabattvertrage--df48be48-66c9-462a-b679-96d1db330da7
Last checked by QUOTA: 2026-08-29
Methodology: https://quotacote.com/a-propos-des-donnees

## Key facts

- Country: Allemagne [FACT]
- Deadline: 2026-11-29 [FACT]
- Last checked by QUOTA: 2026-08-29 [FACT]
- Sector (QUOTA normalisation): Autre [ANALYSIS]
- Summary: QUOTA editorial summary of the source notice [ANALYSIS]

## Entities

- geography: Allemagne
- funder: Techniker Krankenkasse
- buyer: Techniker Krankenkasse

## Limitations

- QUOTA republishes a normalised summary, not the tender documents themselves.
- Commercial details (source dossier, full deadline history, budget) are reserved for subscribers.